Adherence over 48 Weeks in An Antiretroviral Clinical Trial: Variable within Patients, Affected by Toxicities and Independently Predictive of Virological ResponsePythia T. Nieuwkerk, RW ten Kate, Elisabeth H. Gisolf et al.|Antiviral Therapy|2001Cited by 33
Quality of Life in Patients Treated with First-Line Antiretroviral Therapy Containing Nevirapine And/Or EfavirenzA. Catalani, Des Martin, Martin Fisher et al.|Antiviral Therapy|2004Cited by 28